Pacira BioSciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $189.4M | $178.8M | $10.6M | $51.2M |
| FY2025 | $152.0M | $136.7M | $15.3M | $57.5M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $189.4M | $178.8M | $10.6M | $51.2M |
| FY2025 | $152.0M | $136.7M | $15.3M | $57.5M |